Cancer Res Treat.  2021 Oct;53(4):908-916. 10.4143/crt.2021.325.

Life-Sustaining Treatment States in Korean Cancer Patients after Enforcement of Act on Decisions on Life-Sustaining Treatment for Patients at the End of Life

• Won YW
• Kim HJ
• Kwon JH
• Lee HY
• Baek SK
• Kim YJ
• Kim DY
• Ryu H

• KMID: 2521567
• DOI: http://doi.org/10.4143/crt.2021.325

Abstract

Purpose
In Korea, the “Act on Hospice and Palliative Care and Decisions on Life-sustaining Treatment for Patients at the End of Life” was enacted on February 4, 2018. This study was conducted to analyze the current state of life-sustaining treatment decisions based on National Health Insurance Service (NHIS) data after the law came into force.
Materials and Methods
The data of 173,028 cancer deaths were extracted from NHIS qualification data between November 2015 and January 2019.
Results
The number of cancer deaths complied with the law process was 14,438 of 54,635 cases (26.4%). The rate of patient self-determination was 49.0%. The patients complying with the law process have used a hospice center more frequently (28% vs. 14%). However, the rate of intensive care unit (ICU) admission was similar between the patients who complied with and without the law process (ICU admission, 23% vs. 21%). There was no difference in the proportion of patients who had undergone mechanical ventilation and hemodialysis in the comparative analysis before and after the enforcement of the law and the analysis according to the compliance with the law. The patients who complied with the law process received cardiopulmonary resuscitation at a lower rate.
Conclusion
The law has positive effects on the rate of life-sustaining treatment decision by patient’s determination. However, there was no sufficient effect on the withholding or withdrawing of life-sustaining treatment, which could protect the patient from unnecessary or harmful interventions.

Keyword

Life-sustaining treatment; Life-sustaining treatment decisions law; Cancer deaths

Reference

References

1. Miljkovic MD, Jones BL, Miller K. From the Euthanasia Society to physician orders for life-sustaining treatment: end-of-life care in the United States. Cancer J. 2013; 19:438–43.

2. Tanaka M, Kodama S, Lee I, Huxtable R, Chung Y. Forgoing life-sustaining treatment: a comparative analysis of regulations in Japan, Korea, Taiwan, and England. BMC Med Ethics. 2020; 21:99.

3. Choi K. Legal and ethical issues regarding end-of-life care in Korea. J Asian Sociol. 2016; 45:151–64.

4. Kim M. The problems and the improvement plan of the Hospice/Palliative Care and Dying Patient’s Decisions on Life-Sustaining Treatment Act. Korean J Hosp Palliat Care. 2018; 21:1–8.

5. Act on Decisions on Life-Sustaining Treatment for Patients in Hospice and Palliative Care or at the End of Life [Internet]. Sejong: Korea Ministry of Government Legislation;2016. [cited 2021 Jan 10]. Available from: https://www.law.go.kr/LSW/eng/engLsSc.do?menuId=2&section=lawNm&query=Life-sustaining+Treatment&x=14&y=25 .

6. Jin S, Kim J, Lee JY, Ko TY, Oh GM. End-of-life care practice in dying patients after enforcement of Act on Decisions on Life-Sustaining Treatment for Patients in Hospice and Palliative Care or at the End of Life: a single center experience. Korean J Hosp Palliat Care. 2020; 23:93–102.

7. Kim JS, Yoo SH, Choi W, Kim Y, Hong J, Kim MS, et al. Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients. Cancer Res Treat. 2020; 52:917–24.

8. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43:1130–9.

9. Monthly statistics [Internet]. Seoul: National Agency for Management of Life-sustaining Treatment;2020. [cited 2021 Jan 10]. Available from: https://www.lst.go.kr/comm/monthlyStatistics.do .

10. An HJ, Jeon HJ, Chun SH, Jung HA, Ahn HK, Lee KH, et al. Feasibility study of physician orders for life-sustaining treatment for patients with terminal cancer. Cancer Res Treat. 2019; 51:1632–8.

11. Park HY, Kim YA, Sim JA, Lee J, Ryu H, Lee JL, et al. Attitudes of the general Public, cancer patients, family caregivers, and physicians toward advance care planning: a nationwide survey before the enforcement of the Life-Sustaining Treatment Decision-Making Act. J Pain Symptom Manage. 2019; 57:774–82.

12. Kim DY, Lee KE, Nam EM, Lee HR, Lee KW, Kim JH, et al. Do-not-resuscitate orders for terminal patients with cancer in teaching hospitals of Korea. J Palliat Med. 2007; 10:1153–8.

13. Oh DY, Kim JH, Kim DW, Im SA, Kim TY, Heo DS, et al. CPR or DNR? End-of-life decision in Korean cancer patients: a single center’s experience. Support Care Cancer. 2006; 14:103–8.

14. Baek SK, Chang HJ, Byun JM, Han JJ, Heo DS. The association between end-of-life care and the time interval between provision of a do-not-resuscitate consent and death in cancer patients in Korea. Cancer Res Treat. 2017; 49:502–8.

15. Becker G, Sarhatlic R, Olschewski M, Xander C, Momm F, Blum HE. End-of-life care in hospital: current practice and potentials for improvement. J Pain Symptom Manage. 2007; 33:711–9.

16. Celso BG, Meenrajan S. The triad that matters: palliative medicine, code status, and health care costs. Am J Hosp Palliat Care. 2010; 27:398–401.

17. Choi Y, Keam B, Kim TM, Lee SH, Kim DW, Heo DS. Cancer treatment near the end-of-life becomes more aggressive: changes in trend during 10 years at a single institute. Cancer Res Treat. 2015; 47:555–63.

18. Yun YH, Kwak M, Park SM, Kim S, Choi JS, Lim HY, et al. Chemotherapy use and associated factors among cancer patients near the end of life. Oncology. 2007; 72:164–71.

19. Keam B, Oh DY, Lee SH, Kim DW, Kim MR, Im SA, et al. Aggressiveness of cancer-care near the end-of-life in Korea. Jpn J Clin Oncol. 2008; 38:381–6.

20. The 2019 annual report on the life-sustaining treatment decision system. Seoul: Korea National Institute for Bioethics Policy;2019.